Doxorubicin

tumor necrosis factor ; Homo sapiens







86 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34656704 The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: Behavioral and mechanistic study. 2022 Jan 1
2 34932406 Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals. 2022 May 1
3 32770328 Study on the Molecular Mechanisms Against Human Breast Cancer from Insight of Elemental Distribution in Tissue Based on Laser-Induced Breakdown Spectroscopy (LIBS). 2021 May 2
4 33480330 Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment. 2021 Apr 1
5 33834754 pH-Triggered Copper-Free Click Reaction-Mediated Micelle Aggregation for Enhanced Tumor Retention and Elevated Immuno-Chemotherapy against Melanoma. 2021 Apr 21 2
6 34120620 Biomimetic nanotherapy: core-shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma. 2021 Jun 13 1
7 34547383 Doxorubicin suppresses chondrocyte differentiation by stimulating ROS production. 2021 Dec 1 1
8 31630586 Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity. 2020 Jul 3 1
9 32225068 Upregulation of CASP9 through NF-κB and Its Target MiR-1276 Contributed to TNFα-promoted Apoptosis of Cancer Cells Induced by Doxorubicin. 2020 Mar 26 6
10 32418059 Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis. 2020 Jun 2
11 30503721 A new chemotherapeutic approach using doxorubicin simultaneously with geopropolis favoring monocyte functions. 2019 Jan 15 1
12 30880468 Anti-tumour effects of red blood cell membrane-camouflaged black phosphorous quantum dots combined with chemotherapy and anti-inflammatory therapy. 2019 Dec 1
13 30996116 Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue. 2019 May 31 2
14 31086347 Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. 2019 Jun 1
15 31131472 Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway. 2019 Sep 3
16 31645610 Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines. 2019 Oct 23 2
17 26415122 Cross Talk in HEK293 Cells Between Nrf2, HIF, and NF-κB Activities upon Challenges with Redox Therapeutics Characterized with Single-Cell Resolution. 2017 Feb 20 1
18 28025135 Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer. 2017 Mar 1
19 28096970 Inhibition of Akt phosphorylation attenuates resistance to TNF-α cytotoxic effects in MCF-7 cells, but not in their doxorubicin resistant derivatives. 2016 Dec 1
20 25909710 Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study. 2015 1
21 26225838 Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapy. 2015 Oct 28 4
22 24466321 Tumor vasculature-targeted recombinant mutated human TNF-α enhanced the antitumor activity of doxorubicin by increasing tumor vessel permeability in mouse xenograft models. 2014 1
23 25401416 Cooperative interactions between p53 and NFκB enhance cell plasticity. 2014 Dec 15 4
24 22907335 Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells. 2013 Mar 15 1
25 23866034 Synergy between enzastaurin doxorubicin in inducing melanoma apoptosis. 2013 Nov 2
26 23887603 The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity. 2013 Sep 3 1
27 24336081 TNF/TNF-R1 pathway is involved in doxorubicin-induced acute sterile inflammation. 2013 Dec 12 1
28 21387297 Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-κB via targeting of Mre11. 2012 Jan 15 1
29 21959683 Immunological effects of taxol and adryamicin in breast cancer patients. 2012 Apr 1
30 22429871 A 43 kD protein from the leaves of the herb Cajanus indicus L. modulates doxorubicin induced nephrotoxicity via MAPKs and both mitochondria dependent and independent pathways. 2012 Jun 1
31 22644293 Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients. 2012 Jun 26 1
32 23028726 Doxorubicin induces cytotoxicity through upregulation of pERK-dependent ATF3. 2012 1
33 21097524 TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness. 2011 Feb 6
34 21421044 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. 2011 Jun 1 1
35 19212691 The inhibitory effect of the proinflammatory cytokine TNFalpha on erythroid differentiation involves erythroid transcription factor modulation. 2009 Mar 4
36 18400355 Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms. 2008 May 21 1
37 18505924 Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies. 2008 May 1
38 19967054 Long-term Activation of c-Jun N-terminal Kinase through Receptor Interacting Protein is Associated with DNA Damage-induced Cell Death. 2008 Aug 1
39 16388856 In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation. 2006 Mar 15 1
40 16465414 Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells. 2006 Mar 1
41 16483679 A combined treatment TNF-alpha/doxorubicin alleviates the resistance of MCF-7/Adr cells to cytotoxic treatment. 2006 Feb 5
42 16871999 Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy. 2006 1
43 17013758 Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis. 2006 Nov 1
44 17047073 Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. 2006 Oct 15 2
45 15810080 Hepatic preconditioning of doxorubicin in stop-flow chemotherapy: NF-kappaB/IkappaB-alpha pathway and expression of HSP72. 2005 Apr 14 1
46 15823547 TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells. 2005 May 20 4
47 16437946 [Doxorubicin in antiblastic hyperthermic perfusion in the treatment of advanced soft-tissue sarcoma of the limbs]. 2005 May-Jun 2
48 15053862 Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides. 2004 Apr 1
49 15053878 Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. 2004 Mar 26 1
50 15359114 Resistance to cytotoxic chemotherapy is induced by NK cells in non-Hodgkin's Lymphoma Cells. 2004 Sep 3